Deciding what health care gets covered largely falls to health insurers, and it is a role that consistently fails to win them public favor. Behind the complex machinery of the American health insurance industry lies a fundamental tension between cost containment and patient care. While health plans argue that administrative controls are essential to keeping spiraling medical costs in check, data and public sentiment paint a starkly different picture of the human toll. According to a comprehensive health tracking poll conducted by KFF, prior authorization stands out as the single biggest non-cost-related burden insured adults face when navigating the health care system.
The ongoing debate over prior authorization brings into sharp focus the difficult balancing act managed care organizations must perform. On one side, insurers act as a necessary institutional check against unnecessary procedures, excessive pricing, and treatments that lack rigorous medical evidence. On the other side, the operational reality of delays and denials directly impacts patient health outcomes, strains the doctor-patient relationship, and creates mounting friction for health care providers across the country.
Larry Levitt, Executive Vice President for Health Policy at KFF, notes that while insurers serve an indispensable function in managing systemic expenditures, their methods often come at a severe cost to consumer trust and timely medical access. As health care spending continues to dominate national economic conversations, understanding the underlying drivers of these costs and the mechanisms used to control them has never been more critical.
The Financial Realities Driving High Insurance Premiums
Costly health insurance premiums continue to place a heavy financial strain on consumers, families, and employers alike. However, these rising premiums are not arbitrary; they are driven primarily by systemic spending on hospital care, physician services, and prescription drugs. Among these major categories, hospitals command the largest share of national health expenditures, accounting for nearly a third of total spending. Furthermore, hospital care consistently drives faster growth than virtually any other sector of the broader health care system.
In this environment, health insurers function—however imperfectly—as a counterweight to a heavily consolidated hospital industry. Over decades of mergers, acquisitions, and regional consolidation, many hospital systems have gained immense market power, allowing them to dictate and charge higher prices for routine and specialized care alike. The disparity in pricing is striking. Private insurers routinely pay hospital care prices that are roughly double the rates paid by Medicare. Moreover, these private rates have climbed at a much faster pace, rising by approximately 30 percent for private insurers compared to a 21 percent increase for Medicare over comparable tracking periods.
Faced with these formidable cost pressures, private health insurers maintain a relatively limited toolkit to control prices directly. Lacking the regulatory authority or leverage to unilaterally dictate hospital fees, insurers rely heavily on volume management to curb overall spending. Prior authorization has emerged as their primary operational lever for controlling the volume of medical services rendered.
The Great Divide: Pushing Back Against Volume Versus Denying Patient Care
From the perspective of health insurance companies, prior authorization is viewed as a vital defense mechanism against a fee-for-service medical system that inherently incentivizes doing more rather than less. Insurers argue that pre-service review processes discourage clinical practices that are not medically necessary, shielding the broader risk pool from wasteful spending and inefficient resource allocation.
However, patients and frontline clinicians experience this mechanism through a vastly different lens. To those seeking and delivering care, prior authorization frequently feels less like an evidence-based check and more like an adversarial barrier—an institutional voice saying no to medical interventions that physicians have explicitly determined are necessary for their patients.
This fundamental disconnect has turned administrative review into a major public flashpoint. KFF’s public opinion research underscores the deep frustration felt by everyday consumers. Insured adults across the United States identify prior authorization as the single most burdensome hurdle in their healthcare journeys, surpassing nearly every other administrative obstacle short of the direct cost of care itself.
The ripple effects of these utilization management policies extend far beyond a simple administrative delay. When insurers push back on pre-authorization requests, the immediate result is often that necessary medical services simply do not happen. Beyond individual blocked treatments, the persistent possibility of a denial fundamentally alters how clinicians practice medicine. Knowing in advance that certain specialized tests, procedures, or medications face steep hurdles or outright rejection, doctors frequently modify their ordering habits. Many clinicians order fewer diagnostic tests and therapeutic services simply because they anticipate that complex approval requests will ultimately be denied by the payer.
The Personal Toll of Delays and Denials
The downstream consequences of this system are widely felt by the insured public. Nearly half of all insured adults report that they or a family member have experienced a medical treatment being either delayed or denied by their insurance company within the two-year period prior to being surveyed. For many individuals, these bureaucratic hurdles do not remain minor inconveniences; they translate into tangible, real-world consequences affecting physical health, emotional well-being, and personal financial stability.
When specialized care, surgical procedures, or chronic disease medications are stalled or rejected, patients often experience worsening symptoms, prolonged suffering, and heightened stress. For working families, the administrative battle to overturn a denied claim can consume valuable time and energy, sometimes resulting in unexpected medical debt or forcing difficult choices between paying for daily necessities and securing required healthcare treatments.
These findings suggest that while insurers may view prior authorization as a precise surgical tool for budget management, the public experiences it as a blunt instrument that routinely disrupts medical care.
Ultimately, the structural challenges of the American healthcare system leave very few easy answers. Insurers may be imperfect, often unpopular referees, but the underlying reality remains that some entity must make the difficult decisions regarding what healthcare services get covered and at what price points. As the national conversation around healthcare affordability, administrative burdens, and patient rights continues to evolve, the central question for policymakers, providers, and consumers alike is who can be trusted to make those high-stakes calls most effectively, transparently, and fairly.
